Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Krakow, Poland.
Sci Total Environ. 2011 Nov 15;409(24):5205-9. doi: 10.1016/j.scitotenv.2011.08.068. Epub 2011 Oct 1.
The goal of the study was to test the hypothesis that prenatal Paracetamol exposure increases the risk of developing eczema in early childhood and that this association may be stronger in children who are exposed in fetal period to higher concentrations of fine particulate matter (PM2.5). The study sample consisted of 322 women recruited from January 2001 to February 2004 in the Krakow inner city area who gave birth to term babies and completed 5-year follow-up. Paracetamol use in pregnancy was collected by interviews and prenatal personal exposure to PM2.5 over 48 h was measured in recruited women in the second trimester of pregnancy. After delivery, every three months in the first 24 months of the newborn's life and every 6 months later, a detailed standardized face-to-face interview on the infant's health was administered to each mother by trained interviewers. During the interviews at each of the study periods after birth, a history of eczema was recorded. The incident rate ratio (IRR) for frequency of eczema events over the follow-up was estimated from the Poisson regression model and the overall effect of main exposure variables on eczema was assessed by odds ratios (ORs) by the logistic model. The estimated relative risk of eczema occurring whenever in the follow-up was related significantly neither with prenatal Paracetamol nor higher PM2.5 exposure, however, their joint effect was significant (OR interaction term=6.04; 95%CI: 1.04-35.16). Of potential confounders considered in the analysis only damp/moldy home significantly increased the risk of eczema (OR=1.53; 95%CI: 1.14-2.05). In contrast, there was an inverse significant association between the presence of older siblings and eczema (OR=0.55; 95%CI: 0.35-0.84). The joint effect of the main exposure variables significantly increased frequency of eczema events (IRR=1.78, 95%CI: 1.22-2.61). In conclusion, the findings of the study suggest that Paracetamol use by mothers in pregnancy is not an independent risk factor for eczema in children, however, even very small doses of Paracetamol taken in pregnancy may contribute to the occurrence of allergic symptoms in early childhood if there is prenatal co-exposure to higher airborne fine particulate matter.
产前扑热息痛暴露会增加儿童在幼儿期患湿疹的风险,而这种关联在胎儿期暴露于较高浓度细颗粒物(PM2.5)的儿童中可能更强。研究样本由 2001 年 1 月至 2004 年 2 月在克拉科夫市中心招募的 322 名妇女组成,这些妇女足月分娩并完成了 5 年随访。通过访谈收集了怀孕期间扑热息痛的使用情况,并在招募的妇女妊娠中期测量了 48 小时内个人暴露于 PM2.5 的情况。在新生儿生命的前 24 个月的每三个月以及之后的每 6 个月,由经过培训的访谈员对每位母亲进行详细的标准化面对面访谈,以了解婴儿的健康状况。在每次出生后的研究期间的访谈中,记录了湿疹的病史。通过泊松回归模型估计了随访期间湿疹事件频率的发生率比(IRR),通过逻辑模型评估了主要暴露变量对湿疹的总体影响。通过逻辑模型评估了主要暴露变量对湿疹的总体影响,结果表明,无论在随访期间何时发生湿疹,产前扑热息痛或更高 PM2.5 暴露均与湿疹发生的相对风险无关,但它们的联合效应具有显著性(OR 交互项=6.04;95%CI:1.04-35.16)。在分析中考虑的潜在混杂因素中,只有潮湿/发霉的家庭显著增加了湿疹的风险(OR=1.53;95%CI:1.14-2.05)。相比之下,年龄较大的兄弟姐妹的存在与湿疹呈显著负相关(OR=0.55;95%CI:0.35-0.84)。主要暴露变量的联合效应显著增加了湿疹事件的频率(IRR=1.78;95%CI:1.22-2.61)。总之,研究结果表明,母亲在怀孕期间使用扑热息痛不是儿童湿疹的独立危险因素,但如果在胎儿期同时暴露于较高浓度的空气细颗粒物中,即使服用非常小剂量的扑热息痛也可能导致儿童在幼儿期出现过敏症状。